Evolution of the application of glucocorticosteroid preparations for the local treatment in dermatological practice

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Klemenova I.A.

Volga Federal Medical Research Center, Health Ministry of Russia, Nizhny Novgorod, Russia

Esenin S.A.

Nizhegorodskiĭ nauchno-issledovatel'skiĭ kozhno-venerologicheskiĭ institut Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii

Evolution of the application of glucocorticosteroid preparations for the local treatment in dermatological practice

Authors:

Klemenova I.A., Esenin S.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2011;9(5): 46‑50

Views: 4774

Downloaded: 132

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Klemenova IA, Esenin SA. Evolution of the application of glucocorticosteroid preparations for the local treatment in dermatological practice. Russian Journal of Clinical Dermatology and Venereology. 2011;9(5):46‑50. (In Russ.)

Close metadata

Keywords:

evolution of the application

glucocorticosteroid preparations

local treatment

Advantan

Authors:

Klemenova I.A.

Volga Federal Medical Research Center, Health Ministry of Russia, Nizhny Novgorod, Russia

Esenin S.A.

Nizhegorodskiĭ nauchno-issledovatel'skiĭ kozhno-venerologicheskiĭ institut Minzdravsotsrazvitiia Rossiĭskoĭ Federatsii

List of references:

Belousova T.A., Lukashova N.N. Differentsirovannyi podkhod k vyboru naruzhnykh glyukokortikosteroidov v terapii dermatozov. Klin dermatol i venerol 2006; 3: 74-78.
Albrecht G. Clinical comparision of methylprednizolone aceponate and prednicarbate in chronic eczema. J Eur Acad Dermatol Venerol 1994; 3: Suppl 1: 42-48.
Bieber T., Vick K., Folster-Holst R. et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 2: 184-189.
Fritsch P. Clinical experience with Methylprednisolone aceponate (MPA) in eczem. J Dermatol Treat 1992; 3: Suppl 2: 17-19.
Haneke E. The treatment of atopic dermatitis with methylprednizolone aceponate (MPA), a new topical corticosteroid. J Dermatol Treat 1992; 3: Suppl 2: 13-15.
Luger T.A. Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer index. Leitlinie Deutsch Dermatol Gesellschaft 2004; 7: 629-634.
Mori M., Pimpinelli N., Gianotti B. Topical corticosteroids and unwanted local effects: improving the benefit/risk ratio. Drug Safety 1994; 10: 5: 406-412.
Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. Int J Clin Pract 2006; 60: 1: 85-92.
Zaumseil R.P., Fuhrman H., Kecskes A. et al. Methylprednisolone aceponate (Ad-vantan) - an effective topical corticoid therapy with few side effects. Jabrbuch Dermatol 1992; 3: 247-263.

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.